Sign up Australia
Proactive Investors - Run By Investors For Investors

FYI Resources confirms kaolin resource suitable for high-purity alumina feedstock

The company aims to mine and process its kaolin into high-purity alumina (HPA).
rc drill rig in paddock
Kaolin is a superior quality aluminous clay with industrial value

FYI Resources Ltd (ASX:FYI) has received results from a reverse circulation (RC) drilling program at its 100% owned Cadoux kaolin project in Western Australia.

Importantly, analysis of the results has confirmed that the kaolin is an ideal feedstock for refining into high-purity alumina (HPA), a valuable new-age material.

The resource’s high-grade nature and it being low in deleterious minerals highlight its potential value.

75 drill holes averaging 21.5 metres depth

The RC drill program comprised of 75 holes totalling 1,613 metres for an average hole depth of 21.5 metres.

Drilling was designed to collect data for metallurgical studies and to better understand and interpret the geological model.

FYI’s managing director Roland Hill said: “Having attended the drilling program at site and seeing first hand the visual indications, the results of the second phase RC drilling are very pleasing.

“The drilling program demonstrates FYI is progressing with a very robust development strategy and we will continue to deliver the best possible project outcome.”

Updating the resource model

Data from this drilling will also be incorporated into a revised resource model which is underway.

The current JORC resource totals 16.1 million tonnes grading 11.76% aluminium.

View full FYI profile View Profile

FYI Resources Ltd Timeline

Related Articles

test tubes
January 23 2018
Under former chief executive Peter George and his successor Shaun Chilton, it has been transformed via a series of well-judged, quickly integrated and, crucially, cash generative acquisitions
Drug discovery
April 04 2018
In the group’s 2017 results statement at the end of March, Ray Barlow - who took over as CEO on 6 April 2017 - commented: “We are now focused on the right activities"
Dog skeleton with cannabis plant leaf
The company's lead drug candidate is a cannabis-derived canine pain medication.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use